E-Cigarette or Vaping Product Use–associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report
Year: 2020
Type: article
Abstract: The NHLBI convened a working group on October 23, 2019, to identify the most relevant and urgent research priorities and prevailing challenges in e-cigarette or vaping product use-associated lung injury (EVALI). Experts across multiple disciplines discussed the complexities of the EVALI outbreak, identified research priorities, and recommended strategies to address most effectively its causal factors and improve diagnosis, treatment, and prevention of this disease. Many research priorities were identified, including the need to create national and international registries of patients with EVALI, to track accurately those affected and assess outcomes. The group concluded that biospecimens from subjects with EVALI are urgently needed to help define EVALI pathogenesis and that vaping has disease risks that are disparate from smoking, with the occurrence of EVALI highlighting the importance of broadening e-cigarette research beyond comparators to smoking-related diseases.
Institutions: University of California San Diego, VA San Diego Healthcare System, Vanderbilt University, Vanderbilt University Medical Center, University of California, San Francisco, University of Utah, University of Utah Hospital, University of Utah Health Care, George E. Wahlen Department of VA Medical Center, Virginia Commonwealth University, University of Michigan, Roswell Park Comprehensive Cancer Center, Michael E. DeBakey VA Medical Center, Baylor College of Medicine, University of Pennsylvania, Battelle, The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, American University of Beirut, Portland State University, University of North Carolina at Chapel Hill
Language: English
Subfield: Physiology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W3014992736